Question 1

Does Charles Schwab Investment Management own CTNM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Charles Schwab Investment Management holds 214,082 shares of CTNM (Contineum Therapeutics), worth $3.5M.

Question 2

How many shares of CTNM does Charles Schwab Investment Management own?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management holds 214,082 shares of CTNM (Contineum Therapeutics).

Question 3

What is Charles Schwab Investment Management's CTNM position worth?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management's CTNM position is worth $3.5M.

Question 4

Is Charles Schwab Investment Management buying or selling CTNM?

Accepted Answer

In Q2 2026, Charles Schwab Investment Management increased its CTNM position by 70,073 shares (+48.7%).

Question 5

When did Charles Schwab Investment Management first buy CTNM?

Accepted Answer

Charles Schwab Investment Management already held CTNM in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	214,082	+48.7%	$3.5M	0.0%	$16.39	37
2026-Q1	Increased	144,009	+30.8%	$1.9M	0.0%	$14.10	33
2025-Q4	Decreased	110,061	-0.1%	$1.3M	0.0%	$11.40	0
2025-Q3	Increased	110,178	+323.1%	$1.3M	0.0%	$11.82	41
2025-Q2	Decreased	26,039	-49.1%	$103,375	0.0%	$4.11	0
2025-Q1	Decreased	51,202	-7.5%	$357,390	0.0%	$7.07	0
2024-Q4	Increased	55,330	+27.8%	$810,585	0.0%	$14.47	31
2024-Q3	Decreased	43,295	-16.4%	$828,666	0.0%	$18.84	0
2024-Q2	New	51,772	-	$911,705	0.0%	$17.61	34

CTNM9 quarters

CTNM
9 quarters